Abstract
Cryoablation has increased in utilization as a primary prostate cancer therapy in the past several years. The objective of this report is to report the efficacy and morbidity of modern cryoablation in the community setting.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
